Literature DB >> 15694898

Tailoring warfarin induction doses to reflect individual and disease-specific factors.

Walter Ageno, Alessandro Squizzato, Francesco Dentali, Mark Crowther.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15694898     DOI： 10.1016/j.amjmed.2004.11.015

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  4 in total

1.  Use of signals and systems engineering to improve the safety of warfarin initiation.

Authors:  G Hyun; J Li; A R Bass; A Mohapatra; S C Woller; H Lin; C Eby; G A McMillin; B F Gage
Journal:  J Thromb Thrombolysis       Date:  2016-11       Impact factor: 2.300

Review 2.  Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues.

Authors:  Brian F Gage; Lawrence J Lesko
Journal:  J Thromb Thrombolysis       Date:  2007-10-01       Impact factor: 2.300

3.  Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin.

Authors:  B F Gage; C Eby; J A Johnson; E Deych; M J Rieder; P M Ridker; P E Milligan; G Grice; P Lenzini; A E Rettie; C L Aquilante; L Grosso; S Marsh; T Langaee; L E Farnett; D Voora; D L Veenstra; R J Glynn; A Barrett; H L McLeod
Journal:  Clin Pharmacol Ther       Date:  2008-02-27       Impact factor: 6.875

4.  Therapeutic dosing of acenocoumarol: proposal of a population specific pharmacogenetic dosing algorithm and its validation in north Indians.

Authors:  Saurabh Singh Rathore; Surendra Kumar Agarwal; Shantanu Pande; Sushil Kumar Singh; Tulika Mittal; Balraj Mittal
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.